Overview

Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH

Status:
Terminated
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
To determine whether using a long-acting insulin analog at the time of diagnosis, instead of intermediate-acting insulin, affects the rate of loss of the body's ability to make insulin in children with newly diagnosed type 1 diabetes.
Phase:
N/A
Details
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborator:
Novo Nordisk A/S
Treatments:
Insulin
Insulin Detemir
Insulin Glargine
Insulin, Globin Zinc
Protamines